Status:
UNKNOWN
Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Staphylococcus Aureus Bacteremia
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
The primary objective is to determine if early infectious disease (ID) consultation (defined as within 48 hours of a positive blood culture) will reduce mortality rates from Staphylococcus aureus bact...
Detailed Description
Bacteremia is a serious manifestation of Staphylococcus aureus infection with an attributable mortality as high as 25% in MRSA bacteremia. More than a third of patients end up with complications such ...
Eligibility Criteria
Inclusion
- All inpatients at the National University Hospital with Staphylococcus aureus (both methicillin sensitive and methicillin resistant) bacteremia isolated within the defined time period
Exclusion
- Patients who died or were discharged before the notification from the laboratory
- Neonates
- Polymicrobial bacteremia
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00622882
Start Date
October 1 2007
End Date
December 1 2015
Last Update
January 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital
Singapore, Singapore, 11974